Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_assertion wasGeneratedBy ECO_0000203 NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_assertion wasDerivedFrom befree-20150227 NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_assertion SIO_000772 24757092 NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_assertion evidence source_evidence_literature NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.
- NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_assertion description "[These results indicate that reduction of TNFR2+ T cells in AML postremission phase may result from combined azacitidine/lenalidomide therapy and may contribute to an improved clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748281.RACpmmhRU9ZiWnnB1XbyHHGheJnSPqZwi447eZ9KUntzs130_provenance.